1:18 PM
 | 
Jan 09, 2019
 |  BC Extra  |  Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

Paul-Peter Tak has stepped down from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to join Flagship Pioneering as a venture partner. He was GSK's SVP of R&D, chief immunology officer and development lead.

Evercore ISI hired Ravi Mehrotra as senior managing director for biotechnology equity research. Mehrotra was a partner at MTS Health Partners.

J.P. Morgan hired Ling Zhang as head of healthcare and technology for...

Read the full 292 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >